Mayne Pharma Group Ltd (MYX)

Sydney
Currency in AUD
Disclaimer
3.890
+0.120
(+3.18%)
Closed
High dividend Yield
Day's Range
3.770
3.910
52 wk Range
2.680
7.472
Volume
190,733
Bid/Ask
3.850 / 3.890
Prev. Close
3.77
Open
3.77
Day's Range
3.77-3.91
52 wk Range
2.68-7.472
Volume
190,733
Average Volume (3m)
334,854
1-Year Change
-23.71%
Shares Outstanding
84,250,048
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
434.333
Upside +11,065.380%

Mayne Pharma Group Ltd News

Mayne Pharma Group Ltd Analysis

Mayne Pharma Group Ltd Company Profile

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing generic pharmaceuticals. The Company operates through three segments: International, Branded Products Division (BPD) and Portfolio Products Division (PPD). Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. The BPD segment distributes medically differentiated specialty products in United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The Company's products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.

Employees
967
Market
Australia